{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T08:52:45Z","timestamp":1788079965463,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"name":"the Ministry of Health, Labor, and Welfare of Japan","award":["23AA2003"],"award-info":[{"award-number":["23AA2003"]}]},{"name":"the Ministry of Health, Labor, and Welfare of Japan","award":["22AA2003"],"award-info":[{"award-number":["22AA2003"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Thyroid storm is the most severe manifestation of thyrotoxicosis. Beta-blockers are among the standard treatment regimens for this condition, with propranolol being the historically preferred option. However, 2016 guidelines issued by the Japan Thyroid Association and the Japan Endocrine Society recommend the use of beta-1 selective beta-blockers over nonselective beta-blockers, such as propranolol. Nevertheless, evidence supporting this recommendation is limited. Herein, we aimed to investigate the in-hospital mortality of patients with thyroid storms based on the choice of beta-blockers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>The Diagnosis Procedure Combination database, a national inpatient database in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>Patients hospitalized with thyroid storm between April 2010 and March 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>Propensity-score overlap weighting was performed to compare in-hospital mortality between patients who received beta-1 selective beta-blockers and those who received propranolol. Subgroup analysis was also conducted, considering the presence or absence of acute heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>Among the 2462 eligible patients, 1452 received beta-1 selective beta-blockers and 1010 received propranolol. The crude in-hospital mortality rates were 9.3% for the beta-1 selective beta-blocker group and 6.2% for the propranolol group. After adjusting for baseline variables, the use of beta-1 selective beta-blockers was not associated with lower in-hospital mortality (6.3% vs. 7.4%; odds ratio, 0.85; 95% CI, 0.57\u20131.26). Furthermore, no significant difference in in-hospital mortality was observed in patients with acute heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>In patients with thyroid storm, the choice between beta-1 selective beta-blockers and propranolol did not affect in-hospital mortality, regardless of the presence of acute heart failure. Therefore, both beta-1 selective beta-blockers and propranolol can be regarded as viable treatment options for beta-blocker therapy in cases of thyroid storm, contingent upon the clinical context.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006285","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T11:00:30Z","timestamp":1711710030000},"page":"1077-1086","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort Study*"],"prefix":"10.1097","volume":"52","author":[{"given":"Yuichiro","family":"Matsuo","sequence":"first","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Informatics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/thy.2011.0334","article-title":"Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys.","volume":"22","author":"Akamizu","year":"2012","journal-title":"Thyroid"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"e2848","DOI":"10.1097\/MD.0000000000002848","article-title":"Factors associated with mortality of thyroid storm: analysis using a national inpatient database in Japan.","volume":"95","author":"Ono","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/CCM.0000000000004078","article-title":"Thyroid storm in the ICU: A retrospective multicenter study.","volume":"48","author":"Bourcier","year":"2020","journal-title":"Crit Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1507\/endocrj.EJ16-0336","article-title":"2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).","volume":"63","author":"Satoh","year":"2016","journal-title":"Endocr J"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2125.1975.tb00545.x","article-title":"Adrenergic beta-receptor blockade in hyperthyroidism.","volume":"2","author":"Ramsay","year":"1975","journal-title":"Br J Clin Pharmacol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/thy.2007.0252","article-title":"Thyroid-adrenergic interactions: physiological and clinical implications.","volume":"18","author":"Silva","year":"2008","journal-title":"Thyroid"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.1991.1.273","article-title":"Propranolol and thyroid hormone metabolism.","volume":"1","author":"Wiersinga","year":"1991","journal-title":"Thyroid"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/cen.12949","article-title":"Treatment and management of thyroid storm: analysis of the nationwide surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic criteria and nationwide surveys for thyroid storm.","volume":"84","author":"Isozaki","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"76","DOI":"10.37737\/ace.1.3_76","article-title":"Real world data in Japan: chapter II the Diagnosis Procedure Combination database.","volume":"1","author":"Yasunaga","year":"2019","journal-title":"Annals of Clin Epidemiol"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2188\/jea.JE20210016","article-title":"Intensive care unit occupancy in Japan, 2015-2018: A nationwide inpatient database study.","volume":"32","author":"Ohbe","year":"2022","journal-title":"J Epidemiol"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/CLEP.S354733","article-title":"Considerations for using multiple imputation in propensity score-weighted analysis\u2014a tutorial with applied example.","volume":"14","author":"Eiset","year":"2022","journal-title":"Clin Epidemiol"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting.","volume":"113","author":"Li","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1253\/circj.CJ-22-0566","article-title":"Validity of diagnostic algorithms for cardiovascular diseases in Japanese health insurance claims.","volume":"87","author":"Kanaoka","year":"2023","journal-title":"Circ J"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2125.1978.tb04590.x","article-title":"Comparative trial of atenolol and propranolol in hyperthyroidism.","volume":"6","author":"McDevitt","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.1979.tb01048.x","article-title":"Comparison of propranolol and metoprolol in the management of hyperthyroidism.","volume":"8","author":"Murchison","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00129784-200101010-00001","article-title":"Beta-blockade in heart failure: selective versus nonselective agents.","volume":"1","author":"Metra","year":"2001","journal-title":"Am J Cardiovasc Drugs"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1378\/chest.13-1235","article-title":"Adverse respiratory effect of acute \u03b2-blocker exposure in asthma: A systematic review and meta-analysis of randomized controlled trials.","volume":"145","author":"Morales","year":"2014","journal-title":"Chest"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1573403X09666131117174414","article-title":"Acute decompensated heart failure update.","volume":"11","author":"Teerlink","year":"2015","journal-title":"Curr Cardiol Rev"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/01.CIR.87.5.1435","article-title":"The thyroid and the heart.","volume":"87","author":"Polikar","year":"1993","journal-title":"Circulation"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system.","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/hrt.2006.100628","article-title":"Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism.","volume":"93","author":"Siu","year":"2007","journal-title":"Heart"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/bmj.1.6075.1505","article-title":"Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure.","volume":"1","author":"Ikram","year":"1977","journal-title":"Br Med J"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"2324709617747903","DOI":"10.1177\/2324709617747903","article-title":"Propranolol-induced circulatory collapse in a patient with thyroid crisis and underlying thyrocardiac disease: A word of caution.","volume":"5","author":"Abubakar","year":"2017","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis. Thyroid storm.","volume":"22","author":"Burch","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","article-title":"Validity of diagnoses, procedures, and laboratory data in Japanese administrative data.","volume":"27","author":"Yamana","year":"2017","journal-title":"J Epidemiol"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:10:11Z","timestamp":1746191411000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006285","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,29]]}}}